EHR certification update 1.7.11

CMIO.net presents a weekly update of the EHR products certified by the Office of the National Coordinator of Health IT Authorized Testing and Certification Bodies (ONC-ATCBs). The following EHR certifications were announced recently:

 Vendor; products: Allscripts; Sunrise Emergency Care version 5.5 and Sunrise Acute Care version 5.5
Certification: Stage 1 2011/2012 Complete EHRs
Certifying body: Certification Commission for Health Information Technology (CCHIT)
Certification numbers: CC-1112-498885-1 (Sunrise Emergency Care) and CC-1112-498885-5 (Sunrise Acute Care)

Vendor; product: Cyfluent; Cyfluent Chart version 2.0
Certification: Stage 1 2011/1012 Complete EHR
Certifying body: CCHIT
Certification number: CC-1112-284500-1

Vendor; product: 4medica; 4medica Inpatient Cloud Integrated Health Record version 10.11
Certification: Stage 1 2011/2012 EHR Module
Certifying body: CCHIT
Certification number: CC-1112-401670-1

Vendor; product: Iatric Systems; PHR Connect version 1.3
Certification: Stage 1 2011/2012 EHR Module
Certifying body: CCHIT
Certification number: CC-1112-290560-1

Vendor; product: Medicity; iNexx version 4.0
Certification: Stage 1 2011/2012 Ambulatory EHR Module
Certifying body: Drummond Group
Certification number: 12172010-8507-6

Vendor; product: QuadraMed; QCPR version 5.2.0
Certification: Stage 1 2011/2012 Complete EHR
Certifying body: CCHIT
Certification number: CC-1112-147300-1

Vendor; product:
Quest Diagnostics; Care 360 EHR version 2010.2
Certification: Stage 1 2011/2012 Complete EHR
Certifying body: CCHIT
Certification number: CC-1112-936980-1

Click here to access the ONC's Certified Health IT Product List.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.